Fevertree Drinks (FEVR) AI Stock Analysis

• Market Cap: £1.14B
• Dividend Yield: 1.72%
• Average Volume (3M): 343.37K
• Price to Earnings (P/E): 44.9
• Beta (1Y): 1.36
• Revenue Growth: 1.13%
• EPS Growth: 58.33%
• Country: UK
• Employees: 380
• Sector: Consumer Defensive
• Sector Strength: 55
• Industry: Beverages - Non-Alcoholic
• EPS (TTM): 0.04
• Shares Outstanding: 121,312,080
• 10 Day Avg. Volume: 361,184
• 30 Day Avg. Volume: 343,367
• PEG Ratio: -1.08
• Price to Book (P/B): 5.02
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 858.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £832.63
• Price Target Upside: -12.17% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 76 Outperform
• Price Target: 1,061.00p ▲(11.92%Upside)

Fevertree Drinks demonstrates strong financial performance and positive technical indicators, making it a potentially attractive investment. The active share buyback program further enhances shareholder value. However, the high P/E ratio suggests potential overvaluation, which may pose a risk. The absence of recent earnings call details limits insight into management's outlook and strategic direction.

Positive Factors

Growth Potential

Expanded distribution offers significant growth potential: Molson serves over 500k accounts in the US, compared to 75k for Fever-Tree, which theoretically implies around 7x distribution expansion potential.

Market Position

Fevertree Drinks PLC retains its number one position across both channels in the UK.

US Market Momentum

Fever-Tree continues to deliver strong momentum in the US, with underlying brand performance well ahead of the competition.

Negative Factors

Profit Expectations

Profit warning implies reset of expectations: Fever-Tree now expects low-single digit sales growth with an adjusted EBITDA margin of 11% to 13% as it transitions the US business.

Stock Performance

Since being added to the Sell list, Fever-Tree shares are down -30% vs FTSE World Europe up +3% and GS Consumer Staples down -8%.

Tariffs Impact

The 10% tariff on UK imports into the US will be shared equally between Fever-Tree and Molson Coors, impacting short-term financials.

Fevertree Drinks Business Overview & Revenue Model

Company Description

Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, Clementine tonic water, ginger beer, ginger ale, and cola distillers. It sells its products under Fever-Tree brand name to pubs, bars, and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Fevertree Drinks generates revenue through the sale of its premium mixer products to a diverse customer base, including retailers, bars, restaurants, and wholesalers. The company's business model is centered around producing and distributing a wide range of mixers that are often positioned as high-end or luxury products. Key revenue streams include domestic sales in the UK market as well as international sales, with significant contributions from North America and Europe. Fevertree has established strategic partnerships with key distributors and retailers to expand its market presence and drive sales in various regions. Additionally, the brand's strong marketing efforts and focus on quality ingredients help maintain its premium pricing strategy, which contributes to its profitability.

Fevertree Drinks Financial Statement Overview

Summary

Fevertree Drinks shows strong financial health with consistent revenue growth, robust cash flow, and a solid balance sheet. The company has low debt and high equity, supporting its stability and growth prospects, although net profit margins could be improved.

Income Statement

Fevertree Drinks has shown consistent revenue growth over the years, with a notable increase from 2023 to 2024. The gross profit margin and EBIT margin remain solid, indicating effective cost management. However, the net profit margin is relatively moderate due to industry competition. The company's strong EBITDA margin highlights operational efficiency.

Balance Sheet

The company maintains a robust balance sheet with a healthy equity ratio. Fevertree Drinks has low debt levels, resulting in a favorable debt-to-equity ratio. The return on equity is strong, reflecting effective use of shareholders' funds. However, the company's asset base growth is moderate, suggesting a focus on maintaining financial stability.

Cash Flow

Fevertree Drinks demonstrates a strong cash flow position, with significant free cash flow growth from 2023 to 2024. The operating cash flow to net income ratio indicates efficient cash generation relative to profits. The free cash flow to net income ratio is also robust, underscoring the company's ability to generate cash beyond its net earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	368.50M	364.40M	344.30M	311.10M	252.10M
Gross Profit	138.40M	109.00M	118.80M	130.90M	116.30M
EBITDA	45.70M	30.80M	37.20M	60.60M	55.60M
Net Income	24.40M	15.40M	24.90M	44.60M	41.70M
Balance Sheet
Total Assets	321.90M	313.70M	311.60M	336.10M	298.40M
Cash, Cash Equivalents and Short-Term Investments	96.00M	59.90M	95.30M	166.20M	143.10M
Total Debt	12.10M	15.20M	16.90M	2.90M	1.90M
Total Liabilities	75.20M	75.90M	72.40M	54.50M	45.80M
Stockholders Equity	246.70M	237.80M	239.20M	281.60M	252.60M
Cash Flow
Free Cash Flow	56.10M	-13.40M	1.40M	42.20M	35.50M
Operating Cash Flow	70.20M	-3.80M	8.50M	46.80M	38.10M
Investing Cash Flow	-10.80M	-9.60M	-10.00M	-4.30M	-3.80M
Financing Cash Flow	-23.60M	-23.10M	-70.70M	-19.30M	-19.60M

Fevertree Drinks Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 948.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FEVR, the sentiment is Positive. The current price of 948 is above the 20-day moving average (MA) of 911.95, above the 50-day MA of 868.91, and above the 200-day MA of 754.40, indicating a bullish trend. The MACD of 18.75 indicates Negative momentum. The RSI at 64.48 is Neutral, neither overbought nor oversold. The STOCH value of 78.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:FEVR.

Fevertree Drinks Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PFD	79 Outperform	£1.71B	13.91	9.02%	1.04%	5.90%	11.24%
FEVR	76 Outperform	£1.14B	44.88	10.23%	1.72%	1.13%	58.33%
BAG	76 Outperform	£773.17M	19.41	13.01%	2.95%	5.10%	3.23%
CCH	75 Outperform	£14.41B	20.79	26.05%	1.60%	2.77%	26.43%
NICL	73 Outperform	£535.63M	30.00	19.67%	0.01%	1.21%	-2.98%
Sector *	60 Neutral	HK$17.56B	11.08	0.20%	5.34%	2.68%	-48.29%
CCR	56 Neutral	£614.10M	54.10	2.40%	3.64%	-2.68%	-511.88%

Fevertree Drinks Corporate Events

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has executed a share buyback program, purchasing 51,183 ordinary shares at prices ranging from 928.00 to 952.00 pence per share, with a weighted average price of 941.5763 pence. This move, conducted through Investec Bank, is part of a previously announced buyback program and reflects the company’s strategy to manage its capital structure, potentially enhancing shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback Program

Fevertree Drinks PLC has executed a share buyback, purchasing 36,821 ordinary shares at a weighted average price of 924.5312 pence per share. This move, authorized by shareholders, is part of a previously announced buyback program and aims to cancel the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s financial health.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback Program

Fevertree Drinks PLC has announced the purchase of 70,008 of its own ordinary shares, as part of a buyback program initiated earlier in the year. This move, executed through Investec Bank, reflects the company’s strategy to manage its share capital and potentially enhance shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Announces Total Voting Rights Update

Fevertree Drinks PLC has announced that its total issued share capital consists of 121,418,908 ordinary shares, each with one voting right, resulting in a total of 121,418,908 voting rights. This figure is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, potentially impacting shareholder engagement and regulatory compliance.

The most recent analyst rating on (GB:FEVR) stock is a Sell with a £593.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback

Fevertree Drinks PLC announced the repurchase of 61,777 ordinary shares as part of its share buyback program authorized by shareholders. The shares were purchased at a weighted average price of 934.3606 pence and will be canceled, potentially enhancing shareholder value and optimizing the company’s capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has repurchased 89,041 of its own ordinary shares as part of a buyback program announced earlier in February 2025. The shares were bought at prices ranging from 892 to 913 pence and will be canceled, which could potentially enhance shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback Program

Fevertree Drinks PLC has executed a share buyback, purchasing 48,295 ordinary shares at prices ranging from 892 to 910 pence, with a weighted average price of 899.9107 pence. This move is part of a previously announced buyback program and aims to cancel the purchased shares, potentially impacting the company’s share value and benefiting shareholders by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced a share buyback transaction, purchasing 67,549 ordinary shares at an average price of 915.3627 pence per share. This move is part of a previously announced buyback program and the company intends to cancel the purchased shares, which could potentially enhance shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Enhances Shareholder Value with Share Buyback

Fevertree Drinks PLC has announced the repurchase of 90,000 ordinary shares as part of its ongoing share buyback program. The shares were purchased at prices ranging from 886.00 to 911.00 pence and will be canceled, which is expected to enhance shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 56,672 of its ordinary shares, as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 918 to 930 pence and will be canceled, a move that could potentially enhance shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Announces Share Buyback as Part of Strategic Program

Fevertree Drinks PLC announced a share buyback, purchasing 36,649 ordinary shares at prices ranging from 914 to 928 pence per share. This move, part of a previously announced buyback program, aims to cancel the repurchased shares, potentially impacting the company’s share value and signaling confidence in its financial health.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Enhances Shareholder Value with Share Buyback

Fevertree Drinks PLC announced the purchase of 82,489 ordinary shares as part of its share buyback program, with plans to cancel these shares. This move is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Market Position

Fevertree Drinks PLC announced the repurchase of 82,292 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, signaling confidence in its market position.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has executed a share buyback program, purchasing 80,104 ordinary shares at a weighted average price of 906.6489 pence per share. The company plans to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of shares outstanding and increasing the value of remaining shares.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback as Part of Ongoing Program

Fevertree Drinks PLC announced the repurchase of 31,034 ordinary shares as part of its buyback program, initially announced in February 2025. The shares were purchased at prices ranging from 894 to 907 pence and will be canceled, potentially impacting the company’s stock value and shareholder equity.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fever-Tree Director Purchases Significant Shares, Signaling Confidence

Fever-Tree announced that David Lapp, a Non-Executive Director, purchased 24,590 ordinary shares in the company at an average price of USD 12.28 per share via the US OTC Markets. This transaction highlights the confidence of the company’s management in its market position and future prospects, potentially impacting stakeholder perceptions positively.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback as Part of Strategic Program

Fevertree Drinks PLC has repurchased 56,428 of its own ordinary shares at prices ranging from 880.00 to 903.00 pence per share, with a weighted average price of 891.9747 pence. The company plans to cancel these shares as part of a buyback program announced in February 2025, which may impact the company’s stock value and shareholder equity by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC announced the repurchase of 57,187 of its ordinary shares at a weighted average price of 899.9966 pence per share, with the intention to cancel these shares. This buyback, part of a previously announced program, is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback as Part of Strategic Program

Fevertree Drinks PLC has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 873.00 to 893.00 pence, with a weighted average price of 883.0958 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s stock value and signaling confidence in its financial health.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback

Fevertree Drinks PLC announced the repurchase of 34,128 ordinary shares as part of its ongoing buyback program. This move, conducted through Investec Bank plc, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 16,394 ordinary shares as part of a buyback program initiated in February 2025. The shares were acquired at prices ranging from 867 to 887 pence and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced a share buyback, purchasing 40,682 ordinary shares at prices ranging from 873 to 890 pence per share, with a weighted average price of 883.4405 pence. This move, part of a previously announced buyback program, aims to enhance shareholder value and reflects the company’s strategic focus on optimizing its capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fever-Tree Passes All Resolutions at AGM, Strengthening Market Position

Fever-Tree announced that all resolutions were passed at its Annual General Meeting, indicating strong shareholder support and potentially reinforcing its market position as a leading supplier in the premium mixers industry. This outcome may positively impact the company’s operations and reassure stakeholders of its strategic direction.

The most recent analyst rating on (GB:FEVR) stock is a Buy with a £11.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has repurchased 26,202 of its own ordinary shares at a weighted average price of 885.4531 pence per share. This move is part of a buyback program announced earlier in the year, aimed at reducing the number of shares in circulation, which could potentially enhance shareholder value by increasing earnings per share.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fever-Tree Reports Steady Growth and Strategic Developments

Fever-Tree reports steady trading performance, with significant progress in the US market following a strategic partnership with Molson Coors. The company maintains its leading position in the UK and shows growth in Europe, despite muted sales in Germany. Fever-Tree has initiated local production in Australia to support brand momentum. A recent 10% tariff on UK imports to the US will be shared with Molson Coors, with plans to mitigate its impact through on-shored production. The company is also executing a share buyback program, reflecting a strong balance sheet and focus on cash flow generation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fever-Tree Reports Strong US Growth and Strategic Partnership Progress

Fever-Tree Drinks plc has announced a trading update ahead of its Annual General Meeting, highlighting its strategic partnership with Molson Coors in the US, which is expected to drive significant growth. The company maintains its strong market position in the UK and Europe, with local production beginning in Australia to support market share growth. Fever-Tree is also managing the impact of a new 10% tariff on UK imports into the US through shared costs with Molson Coors and plans for on-shored US production. The company has initiated a share buyback program, reflecting its strong balance sheet and cash flow prospects, and remains focused on investment opportunities and potential M&A activities.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £8.60 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Sees Change in Major Shareholder Holdings

Fevertree Drinks PLC has announced a change in major holdings, with The Capital Group Companies, Inc. increasing its voting rights to 5.144183%. This acquisition of voting rights signifies a strategic move by The Capital Group, potentially impacting Fevertree’s future decisions and influencing its market positioning. The shares are managed under the discretionary investment management of Capital Group’s affiliates, indicating a strong institutional interest in Fevertree’s operations.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback Program

Fevertree Drinks PLC announced the repurchase of 56,611 of its ordinary shares, as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 856.00 to 880.00 pence and will be canceled, which may positively impact the company’s stock value by reducing the number of shares in circulation, potentially enhancing shareholder value.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 57,570 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move aligns with the company’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in its financial management.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Announces Total Voting Rights Update

Fevertree Drinks plc announced that its total issued share capital consists of 122,277,559 ordinary shares, each with one voting right, resulting in the same number of total voting rights. This information is crucial for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the repurchase of 35,613 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 874 to 885 pence and will be canceled, which could potentially enhance shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC announced the purchase of 48,008 ordinary shares as part of its share buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 60,000 of its ordinary shares, as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 860 to 883 pence and will be canceled, potentially enhancing shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback Program

Fevertree Drinks PLC announced the repurchase of 37,797 of its ordinary shares, with prices ranging between 860.00 and 880.00 pence per share, as part of a buyback program initiated earlier in the year. This move, conducted through Investec Bank, is intended to cancel the repurchased shares, potentially impacting the company’s stock value and shareholder equity by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the repurchase of 49,792 ordinary shares as part of its share buyback program, with plans to cancel the purchased shares. This move, executed through Investec Bank, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 871.00 to 905.00 pence, with a weighted average price of 896.1786 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Boost Shareholder Value

Fevertree Drinks PLC has announced the repurchase of 54,917 ordinary shares as part of its ongoing buyback program, with prices ranging from 875 to 887 pence per share. This strategic move, authorized by shareholders, is intended to enhance shareholder value by reducing the number of outstanding shares, potentially improving earnings per share and signaling confidence in the company’s future prospects.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Strategic Share Buyback

Fevertree Drinks PLC has executed a share buyback program, purchasing 59,878 ordinary shares at prices ranging from 859 to 887 pence per share, with a weighted average price of 880.5816 pence. This move, authorized by shareholders, is part of a strategic initiative announced earlier in February 2025, and the company plans to cancel the repurchased shares, potentially impacting its market positioning and shareholder value.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Grants Share Options to Executive Directors

Fevertree Drinks plc has announced the grant of options over 380,286 ordinary shares to its Executive Directors under the Long Term Incentive Plan. The options, issued to CEO Tim Warrillow and CFO Andy Branchflower, are set to vest in 2028, contingent on performance conditions from 2025 to 2027. This move aligns with the company’s strategy to incentivize leadership and potentially strengthen its market position.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Initiates Share Buyback Program

Fevertree Drinks PLC has announced a share buyback program, purchasing 32,043 ordinary shares at a weighted average price of 860.9356 pence per share. This move, authorized by shareholders, is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the purchase of 56,861 ordinary shares as part of its share buyback program, authorized during the 2024 Annual General Meeting. The shares were bought at prices ranging from 854 to 886 pence and will be canceled, which is expected to enhance shareholder value and optimize the company’s capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has executed a share buyback, purchasing 53,866 ordinary shares at a weighted average price of 864.1817 pence per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s financial health.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC has announced the purchase of 58,769 ordinary shares as part of a buyback program authorized by shareholders at the 2024 Annual General Meeting. The shares were bought at prices ranging from 843.00 to 858.00 pence, with a weighted average price of 853.3752 pence. This move is part of a strategic initiative to manage the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC has executed a share buyback program, purchasing 59,733 ordinary shares at a weighted average price of 857.9776 pence per share. This move, authorized by shareholders, is part of a broader strategy announced in February 2025, aimed at optimizing the company’s capital structure by canceling the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s future performance.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the purchase of 41,654 ordinary shares as part of its share buyback program, which was authorized by shareholders in 2024. The shares were acquired at prices ranging from 841 to 864 pence and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1000.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the repurchase of 44,166 of its ordinary shares as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 828.00 to 848.00 pence, with a weighted average price of 834.6532 pence, and the company plans to cancel these shares. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure.

Fevertree Drinks Executes Share Buyback as Part of Strategic Program

Fevertree Drinks PLC announced a share buyback transaction, purchasing 49,348 ordinary shares at a weighted average price of 822.0948 pence per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s stock value and shareholder equity.

Fevertree Drinks PLC Announces Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 52,993 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 802.00 to 818.00 pence, with a weighted average price of 809.1636 pence. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 54,162 ordinary shares, as part of a buyback program initiated in February 2025, with plans to cancel these shares. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure, potentially impacting its market positioning positively.

Fevertree Drinks Announces Share Buyback as Part of Strategic Capital Management

Fevertree Drinks PLC has announced a buyback of 40,994 of its ordinary shares, executed through its broker, Investec Bank plc. The shares were purchased at prices ranging from 815.00 to 822.00 pence, with a weighted average price of 819.5199 pence. The company plans to cancel these shares, which is part of a buyback program initiated in February 2025. This move may impact the company’s share value and is a strategic decision to manage its capital structure, potentially benefiting shareholders by increasing earnings per share.

Fevertree Executes Share Buyback to Enhance Value

Fevertree Drinks PLC has announced the repurchase of 21,275 ordinary shares as part of its ongoing buyback program. The shares were purchased at a weighted average price of 810.3865 pence per share and will be canceled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 60,000 ordinary shares as part of its ongoing buyback program, with plans to cancel the purchased shares. This strategic move, executed through Investec Bank, is aimed at enhancing shareholder value and reflects the company’s confidence in its financial position, potentially impacting its stock performance and market perception positively.

Fevertree Drinks Announces Share Buyback and Cancellation

Fevertree Drinks PLC has announced the repurchase of 60,000 of its ordinary shares at a weighted average price of 794.9749 pence per share. This buyback is part of a previously announced program and the company intends to cancel the purchased shares, which could potentially enhance shareholder value by reducing the number of shares outstanding.

Fevertree Drinks Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC announced the repurchase of 56,489 ordinary shares as part of its ongoing buyback program, with plans to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and could potentially enhance shareholder value by reducing the number of shares outstanding.

Fevertree Drinks Enhances Shareholder Value with Strategic Share Buyback

Fevertree Drinks PLC announced the repurchase of 59,806 ordinary shares as part of its share buyback program, with the intention to cancel these shares. This move is part of a strategy to enhance shareholder value and optimize the company’s capital structure, potentially impacting its stock performance and market perception positively.

Fevertree Drinks Executes Share Buyback Program

Fevertree Drinks plc has executed a share buyback, purchasing 60,000 ordinary shares at prices ranging from 762 to 780 pence, with a weighted average price of 768.1231 pence. This move, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s share value and signaling confidence in its financial health.

Fever-Tree Releases 2024 Annual Report and Announces AGM Date

Fever-Tree has released its 2024 Annual Report and announced the date for its Annual General Meeting, which will be held on June 5, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, reinforcing its position as a leader in the premium mixers market.

Fevertree Drinks PLC Executes Share Buyback to Optimize Capital Structure

Fevertree Drinks PLC announced the purchase of 115,242 ordinary shares as part of its share buyback program, with plans to cancel these shares. This move is part of a broader strategy to optimize capital structure and potentially enhance shareholder value, reflecting the company’s proactive approach in managing its financial resources.

Fevertree Drinks PLC Announces Share Buyback

Fevertree Drinks PLC has announced the repurchase of 118,562 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 774 to 790 pence and will be canceled, potentially impacting the company’s share value and signaling confidence in its financial health.

Fevertree Drinks PLC Announces Change in Voting Rights

Fevertree Drinks PLC has announced a change in the breakdown of its voting rights, with Lindsell Train Limited increasing its stake to 11.00% from the previous 10.66%. This adjustment in voting rights could potentially influence the company’s strategic decisions and reflects Lindsell Train’s confidence in Fevertree’s market position.

Fevertree Drinks Announces Share Buyback and Cancellation

Fevertree Drinks PLC has announced the repurchase of 102,070 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has announced the repurchase of 119,118 ordinary shares as part of its buyback program, with the intention to cancel these shares. This move, facilitated by Investec Bank PLC, is part of a broader strategy to enhance shareholder value and optimize the company’s capital structure, potentially impacting its market positioning and stakeholder interests.

Fevertree Drinks PLC Announces Share Buyback and Cancellation

Fevertree Drinks PLC has announced the repurchase of 115,554 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank plc, reflects the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and investor relations.

Fevertree Drinks PLC Executes Share Buyback Program

Fevertree Drinks PLC announced the repurchase of 100,617 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 781 to 787 pence per share, with the company planning to cancel these shares. This move is part of Fevertree’s strategy to manage its share capital effectively, potentially enhancing shareholder value and signaling confidence in its financial health.

Fevertree Drinks PLC Executes Share Buyback to Strengthen Market Position

Fevertree Drinks PLC announced the purchase of 111,021 ordinary shares as part of its share buyback program, with the intention to cancel the acquired shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, indicating a proactive approach in maintaining its market position.

Fever-Tree Extends Share Buyback Program to £100 Million

Fever-Tree Drinks PLC has announced the extension of its share buyback program by £29 million, bringing the total to £100 million. The extension, facilitated by Investec Bank, will continue until the end of 2025, allowing the company to repurchase ordinary shares under pre-set parameters, potentially impacting its market positioning and shareholder value.

Fever-Tree Extends Share Buyback Program to £100 Million

Fever-Tree has announced an extension of its share buyback program, increasing the total to £100 million, with the extension running until the end of 2025. This move, facilitated by Investec Bank, aims to repurchase ordinary shares, reflecting the company’s strategic financial management and potentially impacting its market positioning and shareholder value.

Fevertree Drinks PLC Executes Share Buyback

Fevertree Drinks PLC announced the repurchase of 118,647 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Fevertree Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC has executed a share buyback program, purchasing 99,817 ordinary shares at prices ranging from 731.00 to 762.00 pence, with a weighted average price of 745.2936 pence. This move, authorized by shareholders, aims to cancel the acquired shares, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.

Fevertree Drinks PLC Announces Share Buyback

Fevertree Drinks PLC announced the repurchase of 101,033 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Fevertree Drinks PLC Executes Share Buyback Program

Fevertree Drinks PLC has announced the repurchase of 114,587 of its ordinary shares, as part of a buyback program initiated in February 2025. The shares were purchased at prices ranging from 746 to 802 pence per share, with a weighted average price of 774.4085 pence. The company intends to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of shares outstanding, thereby increasing earnings per share and potentially improving the stock’s market performance.